Related Experiment Video
Updated: Jan 11, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Streamlining Post-PCI Medication Access to Improve DAPT Adherence and Outcomes
Gregory Desrosiers1, Mary McCollough2, Jessie Lipstreuer3
1Department of Cardiology, University of Tennessee Graduate Medical Education, Knoxville, Tennessee, USA.
Integrating hospital outpatient pharmacy services improved access to dual antiplatelet therapy for patients after percutaneous coronary intervention (PCI). This initiative reduced prescription delays and enhanced medication adherence, crucial for preventing stent thrombosis.
Area of Science:
- Cardiovascular Medicine
- Health Systems Pharmacy
- Interventional Cardiology
Background:
- Dual antiplatelet therapy (DAPT) is vital post-percutaneous coronary intervention (PCI) to prevent stent thrombosis.
- Barriers like cost, insurance, patient understanding, and pharmacy stock limit DAPT initiation and adherence.
- Community pharmacies often lack newer, expensive P2Y12 inhibitors, causing prescription delays.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Cardiomyopathy V: Interprofessional Care
Angina V: Nursing Management
Heart Failure V: Medical Management

